Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.
- DOI
- 10.1016/j.eururo.2022.01.032
- Published
- 2022-02-12
- Container
- Eur Urol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eururo.2022.01.032,
title = {Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.},
author = {McGregor B and O'Donnell PH and Balar A and Petrylak D and Rosenberg J and Yu EY and Quinn DI and Heath EI and Campbell M and Hepp Z and McKay C and Steinberg J and Regnault A and Mazerolle F and Galsky MD.},
year = {2022},
journal = {Eur Urol},
doi = {10.1016/j.eururo.2022.01.032},
url = {https://doi.org/10.1016/j.eururo.2022.01.032}
}RIS
TY - JOUR TI - Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial. AU - McGregor B AU - O'Donnell PH AU - Balar A AU - Petrylak D AU - Rosenberg J AU - Yu EY AU - Quinn DI AU - Heath EI AU - Campbell M AU - Hepp Z AU - McKay C AU - Steinberg J AU - Regnault A AU - Mazerolle F AU - Galsky MD. PY - 2022 JO - Eur Urol DO - 10.1016/j.eururo.2022.01.032 UR - https://doi.org/10.1016/j.eururo.2022.01.032 ER -
APA
B, M., PH, O., A, B., D, P., J, R., EY, Y., DI, Q., EI, H., M, C., Z, H., C, M., J, S., A, R., F, M., & MD., G. (2022). Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.. Eur Urol. https://doi.org/10.1016/j.eururo.2022.01.032
Source records
- europe-pmc · retrieved 2026-09-26T21:02:47.425Z